https://doi.org/10.4081/monaldi.2025.3410
Clinical features of respiratory syncytial virus and influenza infections in hospitalized adults across three Italian regions
Submitted: February 5, 2025
Accepted: March 6, 2025
Published: April 1, 2025
Accepted: March 6, 2025
Abstract Views: 279
PDF_EARLY VIEW: 108
SUPPLEMENTARY MATERIAL: 8
SUPPLEMENTARY MATERIAL: 8
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Acute respiratory infections (ARIs) are important causes of morbidity and mortality globally. Respiratory syncytial virus (RSV) is a highly transmissible viral pathogen that is associated with ARIs, with both RSV and influenza virus infections being leading causes of hospitalization in older (especially frail) individuals. However, prospectively collected data on the incidence of RSV infection are scarce. This prospective study sought to estimate the prevalence of and characterize RSV and influenza virus infection in hospitalized patients. Adult patients (≥18 years of age) who were admitted to the respiratory ward of three major hospitals in northern Italy were included in the study and, therefore, had a nasal swab and underwent routine clinical, laboratory, and imaging testing. The primary objective was to estimate the prevalence of influenza virus and RSV infection in these patients. A total of 246 patients were recruited, 36 of whom had a viral or bacterial respiratory infection. Of these, 9 (3.7% of the total included patients or 25.0% of those with any infection) tested positive for the influenza virus, 5 (55.6%) of whom developed acute respiratory failure, with one dying by 3 months post-discharge. A further 3 patients (1.2% of the total included patients or 8.3% of those with any infection) tested positive for RSV. The three patients with RSV had a greater level of dyspnea and greater severity than those with any infection, and all had pneumonia and developed acute respiratory failure, with one dying during hospitalization. Influenza and RSV infections were identified in patients hospitalized in respiratory wards in Northern Italy. The severe nature of the disease in these patients, including a high rate of pneumonia, emphasizes the importance of preventative measures to protect this vulnerable population and, in particular, vaccination.
World Health Organization. The top 10 causes of death. 2024. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed on: 28/10/2024.
Hababou Y, Taleb A, Recoing A, et al. Molecular investigation of a RSV outbreak in a geriatric hospital. BMC Geriatr 2021;21:120.
DOI: https://doi.org/10.1186/s12877-021-02064-6
Centers for Disease Control and Prevention. RSV in older adults. 2024. Available from: https://www.cdc.gov/rsv/older-adults/. Accessed on: 5/11/2024.
Shi T, Vennard S, Jasiewicz F, et al. Disease burden estimates of respiratory syncytial virus related acute respiratory infections in adults with comorbidity: a systematic review and meta-analysis. J Infect Dis 2022;226:S17-21.
DOI: https://doi.org/10.1093/infdis/jiab040
Lee N, Lui GCY, Wong KT, et al. High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections. Clin Infect Dis 2013;57:1069-77.
DOI: https://doi.org/10.1093/cid/cit471
Tanner AR, Dorey RB, Brendish NJ, Clark TW. Influenza vaccination: protecting the most vulnerable. Eur Respir Rev 2021;30:200258.
DOI: https://doi.org/10.1183/16000617.0258-2020
Walsh EE, Pérez Marc G, Zareba AM, et al. Efficacy and safety of a bivalent RSV prefusion F vaccine in older adults. N Engl J Med 2023;388:1465–77.
DOI: https://doi.org/10.1056/NEJMoa2213836
Papi A, Ison MG, Langley JM, et al. Respiratory syncytial virus prefusion F protein vaccine in older adults. N Engl J Med 2023;388:595-608.
DOI: https://doi.org/10.1056/NEJMoa2209604
Zeno EE, Nogareda F, Regan A, et al. Interim effectiveness estimates of 2024 Southern Hemisphere influenza vaccines in preventing influenza-associated hospitalization - REVELAC-i Network, Five South American Countries, March-July 2024. MMWR Morb Mortal Wkly Rep 2024;73:861-8.
DOI: https://doi.org/10.15585/mmwr.mm7339a1
O’Halloran AC, Millman AJ, Holstein R, et al. The burden of all-cause mortality following influenza-associated hospitalizations: Influenza Hospitalization Surveillance Network, 2010–2019. Clin Infect Dis 2025;80:e43-5.
DOI: https://doi.org/10.1093/cid/ciae547
Boattini M, Almeida A, Christaki E, et al. Severity of RSV infection in Southern European elderly patients during two consecutive winter seasons (2017–2018). J Med Virol 2021;93:5152-7.
DOI: https://doi.org/10.1002/jmv.26938
Ackerson B, Tseng HF, Sy LS, et al. Severe morbidity and mortality associated with respiratory syncytial virus versus influenza infection in hospitalized older adults. Clin Infect Dis 2019;69:197-203.
DOI: https://doi.org/10.1093/cid/ciy991
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
DOI: https://doi.org/10.1016/0021-9681(87)90171-8
Papi A, Bellettato CM, Braccioni F, et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006;173:1114-21.
DOI: https://doi.org/10.1164/rccm.200506-859OC
Zhu J, Mallia P, Footitt J, et al. Bronchial mucosal inflammation and illness severity in response to experimental rhinovirus infection in COPD. J Allergy Clin Immunol 2020;146:840-50.e7.
DOI: https://doi.org/10.1016/j.jaci.2020.03.021
Butler CC, Gillespie D, White P, et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. N Engl J Med 2019;381:111-20.
DOI: https://doi.org/10.1056/NEJMoa1803185
Mallia P, Footitt J, Sotero R, et al. Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012;186:1117-24.
DOI: https://doi.org/10.1164/rccm.201205-0806OC
Onwuchekwa C, Moreo LM, Menon S, et al. Underascertainment of respiratory syncytial virus infection in adults due to diagnostic testing limitations: a systematic literature review and meta-analysis. J Infect Dis 2023;228:173-84.
DOI: https://doi.org/10.1093/infdis/jiad012
Wiseman DJ, Thwaites RS, Ritchie AI, et al. Respiratory syncytial virus-related community chronic obstructive pulmonary disease exacerbations and novel diagnostics: A binational prospective cohort study. Am J Respir Crit Care Med 2024;210:994-1001.
DOI: https://doi.org/10.1164/rccm.202403-0649ED
Groves HE, Piché-Renaud PP, Peci A, et al. The impact of the COVID-19 pandemic on influenza, respiratory syncytial virus, and other seasonal respiratory virus circulation in Canada: A population-based study. Lancet Reg Health Am 2021;1:100015.
DOI: https://doi.org/10.1016/j.lana.2021.100015
Centers for Disease Control and Prevention. RSV vaccine guidance for older adults. 2024. Available from: https://www.cdc.gov/rsv/hcp/vaccine-clinical-guidance/older-adults.html. Accessed on: 4/02/2025.
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2025. Available from: https://goldcopd.org/2025-gold-report/. Accessed on: 4/02/2025.
Global Initiative For Asthma. Global strategy for asthma management and prevention. 2024. Available from: https://ginasthma.org/2024-report/. Accessed on: 4/02/2025.
Ethics Approval
The study was approved by the independent ethics committees at each institution (Ferrara, Comitato Etico Area Vasta Emilia Centro on 13th September 2023; Mantua, Comitato Etico Territoriale Lombardia 4, on 19th December 2023; Treviso, Comitato Etico Territoriale Area Nord Veneto, on 20th March 2024).How to Cite
Bigoni, Tommaso, Franco Alfano, Marta Vicentini, Maria João Fonseca, Elisa Turriani, Elisa Vian, Micaela Romagnoli, et al. 2025. “Clinical Features of Respiratory Syncytial Virus and Influenza Infections in Hospitalized Adults across Three Italian Regions”. Monaldi Archives for Chest Disease, April. https://doi.org/10.4081/monaldi.2025.3410.
Copyright (c) 2025 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Pratap Upadhya, Rohit Vadala, Arpitha A, Hospital treatment of severe acute exacerbation of chronic obstructive pulmonary disease in COVID-19 situation: back to basics , Monaldi Archives for Chest Disease: Vol. 90 No. 4 (2020)
- Gopal Chawla, Ram Niwas, Nishant Kumar Chauhan, Naveen Dutt, Taruna Yadav, Priyank Jain, Pancreatic pleural effusion masquerading as right sided tubercular pleural effusion , Monaldi Archives for Chest Disease: Vol. 89 No. 3 (2019)
- Aravind Gandhi Periyasamy, Soundappan Kathirvel, Tanveer Rehman, Amarjeet Singh, Demographic and clinical factors associated with early hospital Coronovirus disease 2019 deaths in a low middle income setting: A record-based analysis of 20,641 deaths from India , Monaldi Archives for Chest Disease: Vol. 92 No. 2 (2022)
- Davorka Muršić, Tajana Jalušić Glunčić, Jelena Ostojić, Sanda Škrinjarić Cincar, Ljiljana Bulat Kardum, Martina Dokoza, Nataša Karamarković Lazarušić, Erim Bešić, Miroslav Samaržija, Andrea Vukić Dugac, Differences in nutritional status of patients with chronic obstructive pulmonary disease between Mediterranean and non-Mediterranean regions in Croatia , Monaldi Archives for Chest Disease: Vol. 94 No. 3 (2024)
- Grazia Mazzeo, Luigi Aronne, Domenica Francesca Mariniello, Valentino Allocca, Maria Ilaria Palma, Francesco Saverio Cerqua, Carlo Iadevaia, Adriano Costigliola, Roberto Parrella, Andrea Bianco, Vanvitelli/Monaldi COVID Group, Which impact for proton pump inhibitors in SARS-CoV-2 pneumonia , Monaldi Archives for Chest Disease: Vol. 91 No. 4 (2021)
- Nitesh Gupta, Sumita Agrawal, Pranav Ish, Suruchi Mishra, Rajni Gaind, Ganapathy Usha, Balvinder Singh, Manas Kamal Sen, *Safdarjung Hospital COVID 2019 working group, Clinical and epidemiologic profile of the initial COVID-19 patients at a tertiary care centre in India , Monaldi Archives for Chest Disease: Vol. 90 No. 1 (2020)
- E. Radzikowska, J. Pawlowski, M. Chabowski, R. Langfort, Constrictive bronchiolitis obliterans in patient with Castelman's disease , Monaldi Archives for Chest Disease: Vol. 63 No. 4 (2005): Pulmonary series
- Shekhar Kunal, Kashish Gupta, Shashi Mohan Sharma, Vijay Pathak, Shruti Mittal, Chandrakant Tarke, Cardiovascular system and COVID-19: perspectives from a developing country , Monaldi Archives for Chest Disease: Vol. 90 No. 2 (2020)
- Rupi Jamwal, Dinesh Singh Kushwaha, Charu Paruthi, Yatish Agarwal, Baljeet Singh Virk, Malini R. Capoor, Comparative analysis of airway invasive aspergillosis and endobronchial spread of tuberculosis on high resolution computed tomography , Monaldi Archives for Chest Disease: Vol. 93 No. 3 (2023)
- E. Nardecchia, L. Perfetti, M. Castiglioni, D. Di Natale, A. Imperatori, N. Rotolo, Bullous lung disease and neurofibromatosis type-1 , Monaldi Archives for Chest Disease: Vol. 77 No. 2 (2012): Pulmonary series
<< < 30 31 32 33 34 35 36 37 38 39 > >>
You may also start an advanced similarity search for this article.
